Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance

Cancer Research - United States
doi 10.1158/0008-5472.can-05-3546
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Functional Annotation of KCNQ1 Variants of Unknown Significance Using Automated Electrophysiology

Biophysical Journal
Biophysics
2017English

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients

Cancer Research and Treatment
Cancer ResearchOncology
2017English

Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India

Cancer Management and Research
Oncology
2018English

Standards for Clinical Use of Genetic Variants

Nature Genetics
Genetics
2014English

Ryanodine Myopathies Without Central Cores—Clinical, Histopathologic, and Genetic Description of Three Cases

Pediatric Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2014English

Assessment of Predicted Enzymatic Activity of Alpha‐N‐acetylglucosaminidase (NAGLU) Variants of Unknown Significance for CAGI 2016

Human Mutation
Genetics
2019English

Utilizing ExAC to Assess the Hidden Contribution of Variants of Unknown Significance to Sanfilippo Type B Incidence

PLoS ONE
Multidisciplinary
2018English

Clinical, Dermoscopic and Histopathologic Findings of Retiform Hemangioendothelioma

Dermatology Practical & Conceptual
2013English

Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance

International Journal of Cell Biology
Cell Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy